NO963128L - Agent for Transdermal Application Containing 14,17-Ethano-Ostra-1,3,5 (10) -Trien-3,17-Diol - Google Patents

Agent for Transdermal Application Containing 14,17-Ethano-Ostra-1,3,5 (10) -Trien-3,17-Diol

Info

Publication number
NO963128L
NO963128L NO963128A NO963128A NO963128L NO 963128 L NO963128 L NO 963128L NO 963128 A NO963128 A NO 963128A NO 963128 A NO963128 A NO 963128A NO 963128 L NO963128 L NO 963128L
Authority
NO
Norway
Prior art keywords
diol
agent
ostra
ethano
trien
Prior art date
Application number
NO963128A
Other languages
Norwegian (no)
Other versions
NO963128D0 (en
Inventor
Clemens Gunther
Ralph Lipp
Ulrich Tauber
Jutta Riedl
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO963128L publication Critical patent/NO963128L/en
Publication of NO963128D0 publication Critical patent/NO963128D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Abstract

Det beskrives et middel for transdermal applikasjon, som er kjenne- tegnet ved at det inneholder 14a,17a- etanoøstra-l,3,5(10)-trien-3,17p-diol, eventuelt i kombinasjon med etter eller flere gestagener.A transdermal application agent is disclosed, characterized in that it contains 14a, 17a-etano-oestra-1,3,5 (10) -triene-3,17β-diol, optionally in combination with one or more progestogens.

NO963128A 1994-01-27 1996-07-26 Agent for Transdermal Application Containing 14,17-Ethano-Ostra-1,3,5 (10) -Trien-3,17-Diol NO963128D0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1994/000213 WO1995020392A1 (en) 1994-01-27 1994-01-27 AGENT, INTENDED FOR TRANSDERMAL ADMINISTRATION, CONTAINING 14α,17α-ETHANOESTRA-1,3,5(10)-TRIENE-3,17β-DIOL

Publications (2)

Publication Number Publication Date
NO963128L true NO963128L (en) 1996-07-26
NO963128D0 NO963128D0 (en) 1996-07-26

Family

ID=8165820

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963128A NO963128D0 (en) 1994-01-27 1996-07-26 Agent for Transdermal Application Containing 14,17-Ethano-Ostra-1,3,5 (10) -Trien-3,17-Diol

Country Status (6)

Country Link
EP (1) EP0741572A1 (en)
JP (1) JPH09510697A (en)
AU (1) AU5971294A (en)
FI (1) FI962993A0 (en)
NO (1) NO963128D0 (en)
WO (1) WO1995020392A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19526864A1 (en) * 1995-07-22 1997-01-23 Labtec Gmbh Hormone patches
US20050090481A1 (en) * 2001-11-09 2005-04-28 Qlt Inc Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883669A (en) * 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
CH674618A5 (en) * 1987-04-02 1990-06-29 Ciba Geigy Ag
HU210549B (en) * 1988-10-27 1995-05-29 Schering Ag Process for producing transdermally applicable pharmaceutical composition containing gestodene
DE3838779A1 (en) * 1988-11-11 1990-05-17 Schering Ag 14 (ALPHA), 17 (ALPHA) ETHANO ESTRATRIENE
DE4227989A1 (en) * 1992-08-21 1994-06-09 Schering Ag Agent for transdermal application containing 3-keto-desogestrel

Also Published As

Publication number Publication date
JPH09510697A (en) 1997-10-28
FI962993A (en) 1996-07-26
EP0741572A1 (en) 1996-11-13
NO963128D0 (en) 1996-07-26
AU5971294A (en) 1995-08-15
WO1995020392A1 (en) 1995-08-03
FI962993A0 (en) 1996-07-26

Similar Documents

Publication Publication Date Title
NO307325B1 (en) Agent for transdermal application containing 3-ketodesogestrel
IS5241A (en) (Hetero) non-steroidal, non-steroidal mixed steroid with androgenic activity
NO845194L (en) MULTI-STEP COMBINATION PREPARATION AND USE OF THIS AS ORAL ANTICONCTION AGENT
DE69839893D1 (en) Anti-estrogenic steroids, pharmaceutical compositions and uses thereof
WO1999012531A3 (en) Hormonal contraceptive
HUP9903515A3 (en) 21-substituted progesterone derivatives as new antiprogestational agents medicoments containing the same, use thereof
TR199902205T2 (en) Medicinal composition containing a lipophilic inert gas.
BR0106127A (en) Multifunction absorbent article
ZA200007299B (en) Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol.
CA2001618A1 (en) Gestodene-containing agent for transdermal administration
ZA974981B (en) A novel composition for transdermal administration of an estrogen, a progestin or a mixture thereof.
DK2386305T3 (en) Selective estrogen receptor modulator in combination with dehydroepiandrosterone (DHEA) or analogues
DK0771217T3 (en) Solid pharmaceutical forms containing clathrates of the steroid sex hormone ethinyl estadiol
BR9707211A (en) Capsule opening device for use in a powder inhaler
BR0208464A (en) Improvements in or relating to air purifying devices
BR9709021A (en) Detergent composition and use.
SE9400631L (en) Device for prosthetic construction unit and implant
PT956022E (en) HORMONAL COMPOSITION CONSTITUTED BY A ESTROGEN COMPOUND AND BY A PROGESTATIVE COMPOUND
NO963128L (en) Agent for Transdermal Application Containing 14,17-Ethano-Ostra-1,3,5 (10) -Trien-3,17-Diol
KR970002063A (en) Auxiliary beam for wiring and plumbing fixtures
SI1635843T1 (en) Therapy comprising dienogest for hormone replacement and depression
EP0632423A3 (en) Panel for repeatedly positioning, fixing and release of non-selfadhesive sheets.
CA2336654A1 (en) Plaster which contains steroids, and a method for the production and use thereof
DE59508403D1 (en) 14ALPHA, 17ALPHA-C2 BRIDGED 19-NOR PROGESTERONE DERIVATIVES
Buyon et al. Recommendations for exogenous estrogen to prevent glucocorticoid-induced osteoporosis in premenopausal women with oligo-or amenorrhea: comment on the American College of Rheumatology recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis